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AbstrACt
Objective Animal and in vitro studies suggest that viral 
acute respiratory infection (VARI) can predispose to 
pneumococcal infection. These findings suggest that the 
prevention of VARI can yield additional benefits for the 
control of pneumococcal disease (PD). In population-based 
studies, however, the evidence is not in accordance, 
possibly due to a variety of methodological challenges 
and problems in these studies. We aimed to summarise 
and critically review the methods and results from these 
studies in order to inform future studies.
Methods We conducted a systematic review of 
population-based studies that analysed the association 
between preceding seasonal VARI and subsequent PD. We 
searched MEDLINE, Embase and Global Health databases 
using tailored search strategies.
results A total of 28 studies were included. After critically 
reviewing the methodologies and findings, 11 studies 
did not control for seasonal factors shared by VARI and 
PD. This, in turn, could lead to an overestimation of the 
association between the two illnesses. One case–control 
study was limited by its small sample size (n case=13). 
The remaining 16 studies that controlled for seasonal 
factors suggested that influenza and/or respiratory 
syncytial virus (RSV) infections were likely to be associated 
with the subsequent occurrence of PD (influenza: 12/14 
studies; RSV: 4/5 studies). However, these 16 studies were 
unable to conduct individual patient data-based analyses. 
Nevertheless, these studies suggested the association 
between VARI and subsequent PD was related to additional 
factors such as virus type and subtype, age group, 
comorbidity status, presentation of PD and pneumococcal 
serotype.
Conclusions Population-based studies do not give 
consistent support for an association between preceding 
seasonal VARI and subsequent PD incidence. The main 
methodological challenges of existing studies include 
the failure to use individual patient data, control for 
seasonal factors of VARI and PD, or include other factors 
related to the association (eg, virus, age, comorbidity and 
pneumococcal serotype).
IntrOduCtIOn 
Both viral acute respiratory infection 
(VARI) and pneumococcal disease (PD) 
account for a substantial disease burden 
worldwide, especially in young children and 
the elderly.1–3 The association of VARI and 
subsequent PD was not well recognised until 
the catastrophic 1918 influenza pandemic, 
which resulted in an estimated 40–50 million 
deaths4; it has been suggested that pneu-
mococcus may have been a major cause of 
death.5 Most recently, it was observed that the 
incidence of PD was higher during 2009 influ-
enza H1N1 pandemic period than the same 
period in prepandemic6–10 and postpandemic 
years.7 9 10 
During interpandemic periods, the associa-
tions of seasonal influenza and other seasonal 
respiratory viruses such as respiratory syncy-
tial virus (RSV), human metapneumovirus 
and parainfluenza virus (PIV) with PD inci-
dence are poorly understood and remain 
unclear. In animal and in vitro studies, it has 
been suggested that viral respiratory infection 
could predispose to pneumococcal infection 
and might facilitate pneumococcal transmis-
sion; in turn, this coinfection could induce 
a lethal synergism that is much more severe 
than infection with either pathogen alone 
(a brief summary of findings is displayed in 
online supplementary Table S1). However, 
these studies are all relatively small-scale 
studies and may be subject to publication bias 
favouring reporting of positive findings. In 
strengths and limitations of this study
 ► This is the first review that critically reviewed the 
methods and findings of population-based studies 
that reported an association between viral acute re-
spiratory infection and pneumococcal disease.
 ► Results of studies summarised according to study 
design and methods.
 ► No meta-analysis was conducted due to a variety of 
study designs, data sources and analytical methods 
in the studies so a narrative summary of the meth-
ods and results is provided.
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population-based studies, the findings were inconsistent. 
These studies differed substantially in study design, data 
sources and methods, making it difficult to compare and 
interpret the results across the studies. We conducted a 
systematic review of population-based studies on the asso-
ciation of preceding VARI on the occurrence of PD to 
summarise the methodology and results, critically review 
the findings and present recommendations for future 
studies.
MethOds
search strategy and selection criteria
We searched MEDLINE, Embase and Global Health 
databases using tailored search strategies (search strat-
egies in online supplementary Text S1, Preferred 
Reporting Items for Systematic Reviews and Meta-Anal-
yses (PRISMA) flow chart in figure 1). We restricted 
the search to studies published between 1 January 1990 
and 31 December 2017. We included population-based 
studies with clinically diagnosed PD cases (see next for 
detailed definition). In terms of VARI exposure, we 
accepted the following studies: (1) those with laborato-
ry-confirmed viral infections; (2) those with the Interna-
tion Classification of Diseases (ICD) code for influenza 
and/or RSV infection and (3) those with case definition 
of influenza-like illness (ILI) and bronchiolitis as proxies 
for influenza and RSV, respectively. We excluded animal 
studies and theoretical studies where no population data 
were applied. We focused our review on the association 
of seasonal VARI and PD and thus excluded studies that 
reported pandemic influenza cases only. No language 
restrictions were applied. The reference lists of eligible 
studies were also checked to identify additional studies 
for inclusion. For all included studies, quality assess-
ment was conducted using tailored Critical Appraisal 
Skills Programme checklists for case–control studies and 
Figure 1 Preferred Reporting Items for Systematic Reviews and Meta-Analyses  flow diagram of the literature search. PD, 
pneumococcal disease.
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cohort studies (online supplementary File S1). The review 
was conducted and reported according to the PRISMA 
guidelines (online supplementary File S2). The protocol 
for this systematic review was registered on PROSPERO 
(registration number: CRD42017064760; online supple-
mentary File S3).
definition of Pd
We defined PD as any disease caused by Streptococcus pneu-
moniae (pneumococcus). Since this definition contains a 
broad range of diseases and symptoms, including some 
that are trivial to our review, we adopted a narrower defini-
tion. This narrowed definition includes invasive pneumo-
coccal disease (IPD) and pneumococcal pneumonia (PP). 
We defined IPD as detection of pneumococcus in typical 
sterile sites (eg, blood, pleural and cerebrospinal fluid). 
A detailed category of PD for our review is displayed in 
figure 2. Additionally, we used the term ‘non-pneumonic 
invasive pneumococcal disease (npIPD)’, which referred 
to all IPD without diagnosis of pneumonia, in order to 
differentiate from both invasive and non-invasive PP.
definition of VArI
We defined VARI as a respiratory tract infection with viral 
aetiology. ILI was viewed as a proxy for influenza infection 
in the present review. We defined ILI as a symptomatic 
cough and fever ≥38°C with onset within 7 days.
data extraction
We used a standardised data extraction template to extract 
relevant data from the eligible full-text studies, including 
study design, data source, methods, results and conclu-
sion. The principle summary measures of the association 
between VARI and PD include correlation coefficients, 
risk ratios, rate ratios, ORs and attributable percentage 
of PD to VARI. YL and MP independently extracted the 
data. HN or HC arbitrated any disagreement with the 
extraction.
data analysis
Since it was expected that methodology would differ 
substantially between studies and a quantitative meta-anal-
ysis would not be appropriate, a narrative synthesis was 
conducted. Studies were summarised according to meth-
odology to allow for more appropriate comparisons of 
the results.
In addition, because of the concern of multiple testing, 
we determined the number of tests conducted in each 
study, so a Bonferroni correction could be applied where 
applicable; only the tests relevant to the association 
Figure 2 Category of pneumococcal disease in the present review.
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between VARI and pneumococcal infection were included 
as part of the correction. The Bonferroni-adjusted signif-
icance level was calculated as 0.05 divided by the number 
of relevant statistical tests within a study.
Patient and public involvement
No patients or public were involved in the present study.
results
A total of 28 studies11–38 were eligible and included in 
the review. We noticed a variety of study designs, expo-
sures and outcomes of interest and analytical methods 
in these studies (summarised in online supplementary 
Table S2). Due to the variety, we summarised the studies 
and displayed the results according to study design and 
methods.
Individual patient data-based studies
Individual patient data-based studies during the interpan-
demic period are sparse. Only three studies17 25 29 were iden-
tified (table 1), including two cohort studies17 29 and one 
small case–control study by O’Brien et al.25 The reported 
results consistently supported the role of preceding VARI 
on the occurrence of PD. However, the two cohort studies 
did not attempt to control the seasonal risk factors of 
VARI and PD that could potentially bias the estimated 
effect size.
eCOlOgICAl studIes
In our review, 2511–16 18–24 26–28 30–38 of the 28 studies were 
ecological studies. 1611 13 14 16 18 19 21–24 26 32–38 out of the 
25 ecological studies controlled for seasonal patterns of 
VARI and PD (online supplementary Table S2). Addition-
ally, the study by Stensballe et al29 analysed data at both 
population and individual levels but did not control for 
the seasonal patterns.
Correlation analyses with no control for seasonal patterns
Table 2 shows a summary of 11 studies12–14 20 21 23 24 27 29 30 33 
using correlation analyses without controlling for seasonal 
patterns of VARI and PD. Since all studies conducted 
multiple tests in analysing the correlation (eg, across 
age groups, viruses and lag time between VARI and PD), 
the Bonferroni method was applied to adjust the signifi-
cance level. The correlation between PD and influenza or 
RSV was statistically significant in all five studies14 23 24 29 30 
that analysed population data of all ages (correlation coef-
ficient r: 0.40–0.71 for influenza at no time lag, 0.47–0.77 
for RSV at no time lag).
regression analyses controlling for seasonal patterns
Table 3 shows the summary of the 15 
studies11 13 14 16 18 22–24 26 32 34–38 that controlled for seasonal 
patterns by regression analysis. Results were inconsistent 
among the studies. In all-age population studies, preceding 
influenza infection was likely to be associated with IPD 
(12 studies13 14 16 18 22–24 32 35–38 reported an association 
and two studies11 34 reported no association). According 
to two studies23 24 that reported age-stratified results, the 
association between influenza and IPD was more likely to 
exist among older people than among young children. In 
terms of preceding RSV infection, four14 24 34 37 out of five 
studies14 23 24 34 37 observed an association of RSV with PD 
incidence. Specifically, one study14 found the association 
between RSV and IPD only existed among children<5 
years. Studies reporting other viruses such as ADV and 
PIV were sparse (two14 23 and one23 studies, respectively). 
Five studies14 23 24 34 37 that reported two or more viruses 
demonstrated that the association differed by the type of 
Table 1 Summary of individual patient data-based studies
Study
Study 
period Population VARI
PD (cases 
(n)) Methods Main findings
Edwards
et al17
2005–
2009
All ages
Northern 
Territory, 
Australia
IFV IPD (n=346) Using data from notifiable diseases system, 
relative risk (RR) of IPD calculated in ≤4 w 
after IFV compared with background risk
RR=112.5 (48.9–
224.8)
O’Brien
et al25
1995–
1996
<18 y
Iowa, USA
ILI
IFV A
Severe PP 
(n=13)
Case–control design: case from children 
with severe PP, three controls per case 
selected, from friends of cases or from 
the same primary care practice, matched 
by age (within 1 y of the case). ILI history 
(7–28 d within admission) investigated by 
telephonic interview and IFV A convalescent 
serology collected.
OR (ILI 
history)=12.4 
(1.7–306),
OR (IFV A 
convalescent 
serology)=3.7 
(1.0–18.1)
Stensballe
et al29
1996–
2003
All ages
Denmark
RSV non-
RSV
IPD (n=7787) Prospective cohort study: two exposure 
groups, RSV and non-RSV respiratory 
infection hospitalisations within 30 d
RR for RSV=7.1 
(3.6–14.3),
RR for non-
RSV=4.5 (2.0–10.0)
d, day(s); IFV, influenza virus; ILI, influenza-like illness; IPD, invasive pneumococcal disease; PD, pneumococcal disease; PP, pneumococcal 
pneumonia; RSV, respiratory syncytial virus; VARI, viral acute respiratory infection; w, week(s); y, year(s).
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virus. Moreover, the association could differ among virus 
subtypes (eg, influenza A vs influenza B22 and PIV 1/2 vs 
PIV 3.23 Notably, there are other factors that could influ-
ence the strength of the associations reported in these 
studies. For instance, the association could vary by presen-
tation of PD (invasive PP, IPP vs npIPD32 34 36 and PP vs 
pneumococcal sepsis (PSe))37; preceding VARI was more 
likely to be associated with the occurrence of pneumonia 
than other clinical presentations. Additionally, the results 
from studies in Denmark, where comorbidity status and 
pneumococcal serotype were available, demonstrated 
that influenza had a greater influence on the incidence of 
low-invasiveness serotypes than medium or high invasive-
ness among the low comorbidity group; among the high 
comorbidity group, the pattern was reversed.35 36
Studies using other analyses
Seven ecological studies15 16 19 22 26 28 31 used other analyt-
ical methods (table 4). Except for studies by Hendriks et 
al19 and Toschke et al,31 all studies reported an association 
between VARI and PD.
dIsCussIOn
In our review, we summarised population-based studies 
that evaluated the association of seasonal VARI and subse-
quent PD. To our knowledge, this is the first review that 
summarises the methodology and findings of existing 
epidemiological studies on this topic.
We found that reported associations between VARI and 
subsequent PD were inconsistent among the 28 included 
studies. Only three studies17 25 29 analysed the association 
using individual patient data. The two cohort studies17 29 
did not account for the shared risk factors between VARI 
and PD that influenced their seasonality, substantially 
limiting the inferences that can be made from these 
data while the case–control study25 was limited by its 
small sample size (n case=13). In ecological studies, only 
1611 13 14 16 18 19 22–24 26 32 34–38 of the 2511–16 18–24 26–28 30–38 
ecological studies accounted for seasonal patterns. In 
these studies, we found that influenza and/or RSV 
infections were likely to be associated with the subse-
quent occurrence of PD. For influenza, the association 
was stronger among younger populations compared 
with older adults23 24 while the pattern was reversed for 
RSV.14 Data from multiple studies suggested that virus 
type (five studies)14 23 24 34 37 and subtype (two studies)22 23, 
comorbidity status (two studies)35 36 and pneumococcal 
serotype invasiveness (one study)35 could influence the 
association. However, these 16 ecological studies had 
various population characteristics (eg, age, comorbidity, 
immunity status), PD datasets, VARI datasets and analyt-
ical methods. As such, heterogeneity among the studies, 
along with their ecological nature, limits the amount 
of valid inferences that can be made from the data (as 
summarised above).
Nevertheless, these studies provide important clues for 
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Table 4 Summary of ecological studies using other methods
Study
Study 
period Population VARI
PD 
(cases (n))
Data sources and 
scale for analysis Methods Main findings
Dangor
et al15
2005–2008 <15 y
Soweto, 
South Africa
IFV IPD
(n=636)
Hospitalisation 
and surveillance 
laboratory data, 
monthly
X-11 seasonal 
adjustment method 
to retain seasonal 
components. Peak 
timing compared by 
time series graph.
IFV peak in May–
July, followed by IPD 
(August–October); 
no correlation 
analysis results 
reported
Domenech 
de Cellès
et al16
2000–2014 All ages
France
ILI (as 
a proxy 
for IFV)
IPD
(n=64 542)
National surveillance 
system, weekly
Correlation analysis 
of waveforms of ILI 
and IPD
Correlation of 
peak timing of ILI 
and IPD peak 2: 
0.42 (0.04 to 0.66); 
correlation of total 
cases of ILI and IPD: 
0.31 (0.03 to 0.56)
Hendriks
et al19
2004–2014 All ages
Netherlands
ILI (as 
a proxy 
for IFV)
IPD
(n=6572)
Surveillance data, 
weekly
Cross-correlations 
of the time series 
model (seasonal 
autoregressive 
integrated moving 
average, SARIMA) 
residuals
No significant 
cross-correlations 
observed
Kuster
et al22
1995–2009 All ages
Toronto/
Peel area, 
Canada
IFV IPD
(n=6191)
Population-based 
surveillance, weekly
Spearman correlation 
for phase and 
amplitude between 
IFV and IPD; Granger 
methods to test 
whether influenza 
predicted IPD; Case-
crossover analysis to 
evaluate short-term 
associations
Phase and 
amplitude between 
IFV and IPD not 
correlated; Granger 
test of IFV causing 
IPD: p<0.001; case-
crossover OR: 1.10 
(1.02 to 1.18) at 1 w 
lag
Opatowski
et al26
2001–2004 All ages
France
VARI PM
(n=1383)
Surveillance data, 
weekly
Mathematic model 
of pneumococcus 
transmission, 
to estimate 
the interaction 
parameters between 
VARI and PM
Factor of VARI on 
pneumococcus 
acquisition or 
transmissibility: 
8.7 (4.6 to 14.4); 
factor of VARI on 
pathogenicity: 
92 (28 to 361)
Shrestha
et al28
1989–2009 All ages
Illinois, USA
IFV PP
(n not 
known)
Hospital data, 
weekly
(dataset I from 1989 
to 1997, dataset II 
from 2000 to 2013)
Mathematic model 
of pneumococcal 
pneumonia 
(PP) transmission, 
to estimate 
the interaction 
parameters between 
VARI and PP
Factor of IFV on 
PP susceptibility: 
dataset I 
115 (70 to 200), 
dataset II 
85 (30 to 160)
Toschke
et al31
1997–2003 <16 y
Germany
IFV A IPD
(n=1474)
Surveillance data, 
monthly
Multivariate 
time series analysis 
using ‘3 hour 
algorithm’, which fit 
an autoregressive 
Poisson or negative 
binomial model to 
time series
IFV A season did not 
affect IPD season 
(p=0.49); IFV A peak 
did not precede IPD 
peak
IFV, influenza virus; ILI, influenza-like illness; IPD, invasive pneumococcal disease; PD, pneumococcal disease; PM, pneumococcal meningitis; 
VARI, viral acute respiratory infection; w, week(s); y, year(s).
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VARI and subsequent PD, and thus could help with the 
conception and design of future studies. Ideally, in order 
to understand whether a particular preceding VARI can 
predispose an individual to PD, a prospective cohort study 
that monitors each individual for VARI and pneumo-
coccal infection would be used, allowing analyses at both 
individual and population levels. However, such a design 
would not be feasible or affordable as inter alia pneumo-
coccal infections are rare. Alternatively, the utilisation of 
large-scale routine health data and reliable data linkage 
(through unique individual identifiers) from sources such 
as surveillance data and hospitalisation datasets may be 
feasible in many industrialised countries. An example of 
such data linkage in our review is the study by Stensballe 
et al29 that linked information from four Danish popula-
tion-based registries. While the authors conducted indi-
vidual-level analysis, the results were based on cases tested 
for both the presence of respiratory viruses and pneu-
mococcal infection. The true number of VARI-associated 
PD cases is likely to be significantly higher due to incom-
plete testing of cases; the untested viral-pneumococcal 
cases could represent a crucial source of selection bias. 
Community-based active surveillance can likely address 
the issue of missing cases but such surveillance would 
be labour intensive and less cost effective to conduct. 
Another option is a case–control study, which is afford-
able and practical, but not without its limitations. In addi-
tion to challenges in designing such studies, defining the 
history of VARI is likely to be inaccurate since the timing 
of viral serology may be less accurate (information bias).27 
In the case–control study by O’Brien et al,25 the authors 
used influenza-strain specific convalescent serology as 
evidence for preceding influenza infection. The authors 
also conducted telephone interviews to investigate ILI 
history but they did not mention whether interviewers 
and interviewees were blind to case or control status. 
Moreover, the value of this case–control study is limited 
by its very small sample size (n case=13).
Compared with individual patient data-based studies, 
ecological studies are more feasible, and thus the most 
common study design included in our review (25/28). 
However, there are some caveats when interpreting 
results from ecological studies. First, causality can never 
be inferred from such studies. Second, the results should 
be interpreted at a population level and cannot be gener-
alised to the individual level. Since ecological studies 
used data aggregated into broad categories, the poten-
tial biases introduced by the aggregation should be taken 
into account. For instance, while 16 out of 25 ecolog-
ical studies used weekly data, others used fortnightly or 
monthly data. This may lead to misclassification as the 
time window of the association of VARI on PD suscepti-
bility can be as short as 1 week.39 40 Moreover, data from 
different sources in ecological studies should represent 
the same population.
Apart from the study design, one further challenge 
of analysing the association is accounting for the influ-
ence of seasonal factors of VARI and PD (confounding). 
Both VARI and PD have similar seasonal patterns, and 
thus are likely to correlate as indicated by the correlation 
results from ecological studies. The increased risk of PD 
during an epidemic season could be caused by VARI or 
by seasonal risk factors or by both. In the present review, 
11 studies12 15 17 20 21 27–31 33 did not attempt to control 
for seasonal confounders, likely leading to biased esti-
mations of the association. For example, the study by 
Edwards et al17 reported a relative risk as high as 112.5 
when not adjusting any seasonal factors. One way to 
address this problem in such studies would be to match 
the individuals with the onset timing of pneumococcal 
infection, keeping the risk of PD comparable between 
VARI cases and non-VARI cases; for ecological studies, 
regression analysis adding seasonal terms or climatic 
factors (such as temperature and humidity), or cross-cor-
relation analysis of time series controlling for seasonal 
patterns could be considered.
Our review suggests that the association of VARI and 
subsequent PD could vary by virus type14 23 24 34 35 and even 
by subtype.22 23 Studies using combinations of viral infec-
tions such as all virus, influenza +RSV, non-influenza, or 
non-RSV could give biased estimations of the association. 
However, it is not always practical to analyse the associa-
tion by virus type. In ecological studies, different types of 
viruses might cocirculate and thus be highly correlated 
in incidence, making it difficult to determine the role for 
each virus. In terms of PD, most studies used IPD as the 
outcome of interest. However, studies that categorised 
IPD into IPP and npIPD found that the association was 
more pronounced in IPP than in npIPD.32 34 36 A similar 
finding, that the association was stronger in PP than PSe, 
was reported in another study.37 These results suggest VARI 
is more likely to be associated with pneumonic pneumo-
coccal infections than non-pneumonic infections. In our 
review, we excluded studies using information other than 
clinical diagnosis as a proxy for PD (eg, prescription data 
and carriage data). Pneumococcal carriage could have a 
fundamental role in the transmission and incidence of 
PD.41 In a study analysing the impact of pneumococcal 
carriage and viral activity, Weinberger et al34 found npIPD 
was associated with carriage prevalence, whereas IPP was 
associated with bronchiolitis (as a proxy for RSV). The 
authors also proposed that preceding VARI increased 
susceptibility but did not enhance transmission (indi-
cated by carriage prevalence) in children. However, more 
studies are needed to confirm these findings.
The association could also vary by population character-
istics. According to two studies that displayed age-stratified 
results,23 24 the association of influenza and subsequent 
IPD was more likely to exist among older people than 
among young children. Studies by Weinberger et 
al35 36 gauged the association in different comorbidity 
and pneumococcal serotype groups among Denmark 
populations. The results showed that influenza had a 
stronger impact on the incidence of low-invasiveness sero-
types than medium or high invasiveness ones in the low 
comorbidity group, while the pattern reversed in the high 
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comorbidity group. Another study that analysed clinical 
records of 919 patients with PP found that infrequently 
colonising pneumococcal serotypes were more likely to 
cause PP after preceding VARI, particularly in patients 
with immunodeficiency or chronic lung diseases.42 These 
findings suggest the need for future studies to analyse the 
association by age group, pneumococcal serotype and 
comorbidity status. Moreover, the recent introduction of 
pneumococcal vaccines has brought changes in the inci-
dence of serotype-specific PD,43 making the association 
of VARI and PD more complicated to understand. As a 
result, future studies should consider the possible sero-
type-specific influence that pneumococcal vaccines have 
on both individual immunity and herd immunity when 
analysing the association.
In addition to the factors discussed above, additional 
factors may influence the estimates of the association. 
The first is the change over time in the methodology 
of data collection, including changes in test method or 
diagnosis, clinical practice and health-seeking behaviour. 
The second is the possible delay in measurement, which 
happened most often in passive hospital-based studies. 
Third, for ecological studies using aggregated data, 
‘holiday spikes’ could occur due to more social gather-
ings44; besides, weekends and holidays might influence 
timely tests or diagnosis as well as the health-seeking 
behaviour of patients.
To our knowledge, this is the first review to summarise 
and critically appraise the methods and results of popu-
lation-based studies about the association between 
seasonal VARI and subsequent PD. However, this review 
is not without its limitations. First, due to a variety of 
study designs, data sources and analytical methods in 
the studies included, no meta-analysis was conducted in 
the review. As such, we were unable to provide a quan-
titative measure of the association of seasonal VARI and 
PD. Second, no unpublished data sources were included 
in the review, which could mean the data reported 
favours positive associations due to publication bias. 
Thus, caution should be taken when interpreting the 
results. Third, we found many studies tended to conduct 
multiple statistical tests using different subgroups and 
time periods (eg, age group, virus, time lag between VARI 
and PD) without specifying the primary study question a 
priori or making proper statistical adjustments to account 
for multiple testing. This could give rise to an increased 
risk of reporting false positive results. In this review, we 
applied Bonferroni corrections to adjust for the multiple 
tests where deemed necessary. Since the Bonferroni 
method is conservative and we are unable to adjust for 
studies where p values were not given, the adjustment 
in our review is intended for readers’ reference and as 
caveats for future studies.
Given the substantial burden of VARI across the world,1 
even a modest association between VARI and subsequent 
PD could lead to a substantial burden of disease in terms 
of VARI-related PD cases. If proper antibacterial inter-
ventions could be applied to those with higher risk of 
PD due to a preceding VARI, subsequent pneumococcal 
infections could be prevented. The interventions would 
be more effective/better targeted if we could estimate the 
risk (ie, the strength of association) according to timing 
of infection by week/month of a year, age, comorbidity 
status, virus type and status of immunity. In turn, under-
standing the association between VARI and subsequent 
pneumococcal infection can help evaluate the full impact 
of viral vaccine programmes.
In conclusion, the role of seasonal VARI on subsequent 
PD incidence remains controversial in population-based 
studies. Nevertheless, these studies provide valuable 
information and can help with the conception of future 
well-designed studies. Future work could explore the asso-
ciation by timing of infection, age, comorbidity status, 
virus type, pneumococcal serotype and presentation, and 
thus would identify potentially susceptible populations 
with VARI for preventive interventions.
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